Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rotem Katzir

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Nature Communications|June 2, 2022
Estimating tumor mutational burden from RNA-sequencing without a matched-normal sampleRotem Katzir, Noam Rudberg, Keren Yizhak
Proceedings of the National Academy of Sciences of the United States of America|September 16, 2015
Synthetic dosage lethality in the human metabolic network is highly predictive of tumor growth and cancer patient survivalWout Megchelenbrink, Rotem Katzir, Xiaowen Lu, et al.
Scientific Reports|November 30, 2019
The landscape of tiered regulation of breast cancer cell metabolismRotem Katzir, Ibrahim H Polat, Michal Harel, et al.
Cell Systems|May 3, 2016
System-wide Clinical Proteomics of Breast Cancer Reveals Global Remodeling of Tissue HomeostasisYair Pozniak, Nora Balint-Lahat, Jan Daniel Rudolph, et al.
Brain : a Journal of Neurology|July 28, 2022
Astrocyte immunometabolic regulation of the tumour microenvironment drives glioblastoma pathogenicityRita Perelroizen, Bar Philosof, Noga Budick-Harmelin, et al.
Nature Cancer|February 5, 2022
Targeting purine synthesis in ASS1-expressing tumors enhances the response to immune checkpoint inhibitorsRom Keshet, Joo Sang Lee, Lital Adler, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Nature Communications|June 2, 2022
Estimating tumor mutational burden from RNA-sequencing without a matched-normal sampleRotem Katzir, Noam Rudberg, Keren Yizhak
Proceedings of the National Academy of Sciences of the United States of America|September 16, 2015
Synthetic dosage lethality in the human metabolic network is highly predictive of tumor growth and cancer patient survivalWout Megchelenbrink, Rotem Katzir, Xiaowen Lu, et al.
Scientific Reports|November 30, 2019
The landscape of tiered regulation of breast cancer cell metabolismRotem Katzir, Ibrahim H Polat, Michal Harel, et al.
Cell Systems|May 3, 2016
System-wide Clinical Proteomics of Breast Cancer Reveals Global Remodeling of Tissue HomeostasisYair Pozniak, Nora Balint-Lahat, Jan Daniel Rudolph, et al.
Brain : a Journal of Neurology|July 28, 2022
Astrocyte immunometabolic regulation of the tumour microenvironment drives glioblastoma pathogenicityRita Perelroizen, Bar Philosof, Noga Budick-Harmelin, et al.
Nature Cancer|February 5, 2022
Targeting purine synthesis in ASS1-expressing tumors enhances the response to immune checkpoint inhibitorsRom Keshet, Joo Sang Lee, Lital Adler, et al.
Pageof 1